Sign in

CIK 0001326190

  • Non-accelerated filer
  • Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202726770
Phone
+1 862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
  1. 4 Shares withheld for taxes President and CEO gave up 2,243 shares (to pay taxes)
  2. 4 Exercise or conversion Director acquired 60 shares (option exercise)
  3. 4 Open-market sale Director sold 10,150 shares at $9.91 ($100,587)
  4. 4 Open-market sale Director sold 10,352 shares at $9.90 ($102,485)
  5. 4 Open-market sale Director sold 4,015 shares at $10.02 ($40,230)
  6. 4 Shares withheld for taxes President and CEO gave up 2,015 shares (to pay taxes)
  7. 4 Exercise or conversion Director acquired 25,275 shares (option exercise)
  8. 4 Exercise or conversion Director acquired 16,850 shares (option exercise)
  9. 4 Exercise or conversion Director acquired 16,850 shares (option exercise)
  10. 4 Exercise or conversion Director acquired 16,850 shares (option exercise)
  11. 4 Exercise or conversion Director acquired 16,850 shares (option exercise)
  12. 4 Exercise or conversion Director acquired 16,850 shares (option exercise)
  13. 4 Shares withheld for taxes President & CEO gave up 2,015 shares (to pay taxes)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 12 of 34 · 674 filings